S&P 500   3,785.68 (-1.66%)
DOW   30,511.11 (-1.38%)
QQQ   323.70 (-1.49%)
AAPL   143.56 (+0.28%)
MSFT   234.73 (+1.03%)
FB   274.94 (-2.52%)
GOOGL   1,839.51 (-3.59%)
AMZN   3,280.00 (-1.39%)
TSLA   883.38 (+0.03%)
NVDA   520.95 (-3.06%)
BABA   262.53 (-1.27%)
CGC   38.79 (+9.21%)
GE   10.83 (-4.07%)
MU   76.60 (-3.66%)
AMD   90.85 (-4.08%)
NIO   58.35 (-3.25%)
T   29.35 (-1.34%)
F   10.87 (-2.86%)
ACB   11.66 (+9.28%)
BA   194.24 (-3.87%)
DIS   164.21 (-3.16%)
NFLX   537.86 (-4.28%)
GILD   65.57 (-1.69%)
S&P 500   3,785.68 (-1.66%)
DOW   30,511.11 (-1.38%)
QQQ   323.70 (-1.49%)
AAPL   143.56 (+0.28%)
MSFT   234.73 (+1.03%)
FB   274.94 (-2.52%)
GOOGL   1,839.51 (-3.59%)
AMZN   3,280.00 (-1.39%)
TSLA   883.38 (+0.03%)
NVDA   520.95 (-3.06%)
BABA   262.53 (-1.27%)
CGC   38.79 (+9.21%)
GE   10.83 (-4.07%)
MU   76.60 (-3.66%)
AMD   90.85 (-4.08%)
NIO   58.35 (-3.25%)
T   29.35 (-1.34%)
F   10.87 (-2.86%)
ACB   11.66 (+9.28%)
BA   194.24 (-3.87%)
DIS   164.21 (-3.16%)
NFLX   537.86 (-4.28%)
GILD   65.57 (-1.69%)
S&P 500   3,785.68 (-1.66%)
DOW   30,511.11 (-1.38%)
QQQ   323.70 (-1.49%)
AAPL   143.56 (+0.28%)
MSFT   234.73 (+1.03%)
FB   274.94 (-2.52%)
GOOGL   1,839.51 (-3.59%)
AMZN   3,280.00 (-1.39%)
TSLA   883.38 (+0.03%)
NVDA   520.95 (-3.06%)
BABA   262.53 (-1.27%)
CGC   38.79 (+9.21%)
GE   10.83 (-4.07%)
MU   76.60 (-3.66%)
AMD   90.85 (-4.08%)
NIO   58.35 (-3.25%)
T   29.35 (-1.34%)
F   10.87 (-2.86%)
ACB   11.66 (+9.28%)
BA   194.24 (-3.87%)
DIS   164.21 (-3.16%)
NFLX   537.86 (-4.28%)
GILD   65.57 (-1.69%)
S&P 500   3,785.68 (-1.66%)
DOW   30,511.11 (-1.38%)
QQQ   323.70 (-1.49%)
AAPL   143.56 (+0.28%)
MSFT   234.73 (+1.03%)
FB   274.94 (-2.52%)
GOOGL   1,839.51 (-3.59%)
AMZN   3,280.00 (-1.39%)
TSLA   883.38 (+0.03%)
NVDA   520.95 (-3.06%)
BABA   262.53 (-1.27%)
CGC   38.79 (+9.21%)
GE   10.83 (-4.07%)
MU   76.60 (-3.66%)
AMD   90.85 (-4.08%)
NIO   58.35 (-3.25%)
T   29.35 (-1.34%)
F   10.87 (-2.86%)
ACB   11.66 (+9.28%)
BA   194.24 (-3.87%)
DIS   164.21 (-3.16%)
NFLX   537.86 (-4.28%)
GILD   65.57 (-1.69%)
Log in
OTCMKTS:CELTF

Centamin Stock Forecast, Price & News

$1.65
+0.01 (+0.61 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.63
Now: $1.65
$1.65
50-Day Range
$1.59
MA: $1.67
$1.85
52-Week Range
$1.07
Now: $1.65
$3.07
Volume2,095 shs
Average Volume19,800 shs
Market Capitalization$1.91 billion
P/E Ratio20.63
Dividend Yield3.66%
Beta0.92
Centamin plc engages in the exploration, mining, and development of precious metals in Egypt, Burkina Faso, Côte d'Ivoire, Jersey, the United Kingdom, and Australia. The company explores for gold ore deposits. Its principal project is the Sukari Gold Mine project, which covers an area of 160 square kilometers located in the Eastern Desert of Egypt. Centamin plc was incorporated in 1970 and is based in Saint Helier, the Channel Islands.
Centamin logo

MarketRank

Overall MarketRank

1.57 out of 5 stars

Basic Materials Sector

139th out of 814 stocks

Metal Mining Industry

10th out of 89 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 3.1 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Metal mining
Sub-IndustryN/A
Current SymbolOTCMKTS:CELTF
CUSIPN/A
CIKN/A
Phone44-15-3482-8700
Employees1,542
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$652.34 million
Cash Flow$0.18 per share
Book Value$1.12 per share

Profitability

Miscellaneous

Outstanding Shares1,155,955,000
Market Cap$1.91 billion
Next Earnings Date5/17/2021 (Estimated)
OptionableNot Optionable
$1.65
+0.01 (+0.61 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CELTF News and Ratings via Email

Sign-up to receive the latest news and ratings for CELTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Centamin (OTCMKTS:CELTF) Frequently Asked Questions

How has Centamin's stock been impacted by COVID-19 (Coronavirus)?

Centamin's stock was trading at $1.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CELTF shares have increased by 1.9% and is now trading at $1.65.
View which stocks have been most impacted by COVID-19
.

Is Centamin a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centamin in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Centamin stock.
View analyst ratings for Centamin
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Centamin?

Wall Street analysts have given Centamin a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Centamin wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Centamin's next earnings date?

Centamin is scheduled to release its next quarterly earnings announcement on Monday, May 17th 2021.
View our earnings forecast for Centamin
.

How were Centamin's earnings last quarter?

Centamin plc (OTCMKTS:CELTF) issued its earnings results on Wednesday, November, 12th. The basic materials company reported $0.01 EPS for the quarter. During the same period last year, the business earned $0.02 EPS.
View Centamin's earnings history
.

Is Centamin a good dividend stock?

Centamin pays an annual dividend of $0.06 per share and currently has a dividend yield of 3.66%. The dividend payout ratio of Centamin is 75.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Centamin will have a dividend payout ratio of 33.33% next year. This indicates that Centamin will be able to sustain or increase its dividend.
View Centamin's dividend history.

Are investors shorting Centamin?

Centamin saw a increase in short interest in December. As of December 31st, there was short interest totaling 89,600 shares, an increase of 21.1% from the December 15th total of 74,000 shares. Based on an average daily volume of 155,300 shares, the days-to-cover ratio is presently 0.6 days.
View Centamin's Short Interest
.

Who are some of Centamin's key competitors?

Who are Centamin's key executives?

Centamin's management team includes the following people:
  • Mr. Ross Ian Jerrard, CFO & Director (Age 46, Pay $1.06M)
  • Mr. Martin Horgan, CEO & Director (Age 47)
  • Mr. Riaan Nel, Group Accountant
  • Ms. Alexandra Carse, Head of Investor Relations
  • Mr. John Singleton, Head of Corp. Devel.
  • Mr. Craig Murray, Head of Risk
  • Mr. Mark Smith, Group Financial Controller
  • Mr. Darren Le Masurier, Group Company Sec.
  • Mr. Terence Smith, Gen. Mang. of Sukari Operations
  • Mr. Caroline Kashiri, Assistant Company Sec.

What is Centamin's stock symbol?

Centamin trades on the OTCMKTS under the ticker symbol "CELTF."

How do I buy shares of Centamin?

Shares of CELTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Centamin's stock price today?

One share of CELTF stock can currently be purchased for approximately $1.65.

How big of a company is Centamin?

Centamin has a market capitalization of $1.91 billion and generates $652.34 million in revenue each year. The basic materials company earns $87.46 million in net income (profit) each year or $0.08 on an earnings per share basis. Centamin employs 1,542 workers across the globe.

What is Centamin's official website?

The official website for Centamin is www.centamin.com.

How can I contact Centamin?

Centamin's mailing address is 2 Mulcaster Street, Saint Helier Y9, JE2 3NJ. The basic materials company can be reached via phone at 44-15-3482-8700 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.